These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 12023382)
1. Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. Scapini P; Nesi L; Morini M; Tanghetti E; Belleri M; Noonan D; Presta M; Albini A; Cassatella MA J Immunol; 2002 Jun; 168(11):5798-804. PubMed ID: 12023382 [TBL] [Abstract][Full Text] [Related]
2. Angiostatin selectively inhibits signaling by hepatocyte growth factor in endothelial and smooth muscle cells. Wajih N; Sane DC Blood; 2003 Mar; 101(5):1857-63. PubMed ID: 12406896 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a). Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434 [TBL] [Abstract][Full Text] [Related]
4. Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells. Cao Y; Ji RW; Davidson D; Schaller J; Marti D; Söhndel S; McCance SG; O'Reilly MS; Llinás M; Folkman J J Biol Chem; 1996 Nov; 271(46):29461-7. PubMed ID: 8910613 [TBL] [Abstract][Full Text] [Related]
5. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. Ji WR; Castellino FJ; Chang Y; Deford ME; Gray H; Villarreal X; Kondri ME; Marti DN; Llinás M; Schaller J; Kramer RA; Trail PA FASEB J; 1998 Dec; 12(15):1731-8. PubMed ID: 9837863 [TBL] [Abstract][Full Text] [Related]
6. Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells. Redlitz A; Daum G; Sage EH J Vasc Res; 1999; 36(1):28-34. PubMed ID: 10050071 [TBL] [Abstract][Full Text] [Related]
7. Human prostate carcinoma cells express enzymatic activity that converts human plasminogen to the angiogenesis inhibitor, angiostatin. Gately S; Twardowski P; Stack MS; Patrick M; Boggio L; Cundiff DL; Schnaper HW; Madison L; Volpert O; Bouck N; Enghild J; Kwaan HC; Soff GA Cancer Res; 1996 Nov; 56(21):4887-90. PubMed ID: 8895739 [TBL] [Abstract][Full Text] [Related]
8. Selective inhibition by kringle 5 of human plasminogen on endothelial cell migration, an important process in angiogenesis. Ji WR; Barrientos LG; Llinás M; Gray H; Villarreal X; DeFord ME; Castellino FJ; Kramer RA; Trail PA Biochem Biophys Res Commun; 1998 Jun; 247(2):414-9. PubMed ID: 9642142 [TBL] [Abstract][Full Text] [Related]
9. Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen. Falcone DJ; Khan KM; Layne T; Fernandes L J Biol Chem; 1998 Nov; 273(47):31480-5. PubMed ID: 9813061 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of endothelial cell proliferation by the recombinant kringle domain of tissue-type plasminogen activator. Kim HK; Lee SY; Oh HK; Kang BH; Ku HJ; Lee Y; Shin JY; Hong YK; Joe YA Biochem Biophys Res Commun; 2003 May; 304(4):740-6. PubMed ID: 12727218 [TBL] [Abstract][Full Text] [Related]
12. Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. Cao Y; Chen A; An SS; Ji RW; Davidson D; Llinás M J Biol Chem; 1997 Sep; 272(36):22924-8. PubMed ID: 9278456 [TBL] [Abstract][Full Text] [Related]
13. The tumor-suppressing activity of angiostatin protein resides within kringles 1 to 3. MacDonald NJ; Murad AC; Fogler WE; Lu Y; Sim BK Biochem Biophys Res Commun; 1999 Oct; 264(2):469-77. PubMed ID: 10529387 [TBL] [Abstract][Full Text] [Related]
14. Multiple forms of angiostatin induce apoptosis in endothelial cells. Lucas R; Holmgren L; Garcia I; Jimenez B; Mandriota SJ; Borlat F; Sim BK; Wu Z; Grau GE; Shing Y; Soff GA; Bouck N; Pepper MS Blood; 1998 Dec; 92(12):4730-41. PubMed ID: 9845539 [TBL] [Abstract][Full Text] [Related]
15. Soluble tissue actor interferes with angiostatin-mediated inhibition of endothelial cell proliferation by lysine-specific interaction with plasminogen kringle domains. Albrecht S; Magdolen V; Herzog U; Miles L; Kirschenhofer A; Baretton G; Luther T Thromb Haemost; 2002 Dec; 88(6):1054-9. PubMed ID: 12529759 [TBL] [Abstract][Full Text] [Related]
16. Angiogenic balance in human melanoma: expression of VEGF, bFGF, IL-8, PDGF and angiostatin in relation to vascular density of xenografts in vivo. Westphal JR; Van't Hullenaar R; Peek R; Willems RW; Crickard K; Crickard U; Askaa J; Clemmensen I; Ruiter DJ; De Waal RM Int J Cancer; 2000 Jun; 86(6):768-76. PubMed ID: 10842189 [TBL] [Abstract][Full Text] [Related]
17. Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis. Cao R; Wu HL; Veitonmäki N; Linden P; Farnebo J; Shi GY; Cao Y Proc Natl Acad Sci U S A; 1999 May; 96(10):5728-33. PubMed ID: 10318952 [TBL] [Abstract][Full Text] [Related]
18. Mutation of human plasminogen kringle 1-5 enhances anti-angiogenic action via increased interaction with integrin alpha(v)beta(3). Chang PC; Chang YJ; Wu HL; Chang CW; Lin CI; Wang WC; Shi GY Thromb Haemost; 2008 Apr; 99(4):729-38. PubMed ID: 18392331 [TBL] [Abstract][Full Text] [Related]
19. The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF. Kim JH; Kim JC; Shin SH; Chang SI; Lee HS; Chung SI Exp Mol Med; 1999 Dec; 31(4):203-9. PubMed ID: 10630375 [TBL] [Abstract][Full Text] [Related]
20. Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen. Heidtmann HH; Nettelbeck DM; Mingels A; Jäger R; Welker HG; Kontermann RE Br J Cancer; 1999 Dec; 81(8):1269-73. PubMed ID: 10604721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]